Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today presented final first-in-human data for ...
Thanks to a new collaboration, Replit is giving people a simpler way to make money with their vibe-coded apps and websites.
Vibe coding AI startup Replit launched an integration with Visa and a “white glove” customer support program for businesses ...
Visa has announced an undisclosed investment in AI coding platform Replit. The two companies are also exploring how to ...
Replit is continuing its rapid expansion into enterprise software development through a new partnership and investment from ...
Replimune Group, Inc.'s RP1 has failed at the FDA twice, but Makary's resignation keeps a resubmission possible. REPL's cash runway stands at under a year; workforce cuts and RP1 discontinuation are ...